Publications > Journals > Journal of Exploratory Research in Pharmacology > Special Feature

Time: April 11, 2022


Journal: Journal of Exploratory Research in Pharmacology

Special Issue: Natural active ingredient–based nanodrug delivery system for cancer treatment

Guest Editors: Dr. Chao Han, Dr. Zhongrui Li

Status: Open

Submission deadline: October 31, 2022

Publication date: An article will be published online as soon as it is accepted.


Guest Editors’ Profiles:


Image

Chao Han, MD, PhD

Chao Han received his PhD in Medicinal Chemistry in 2016 from China Pharmaceutical University, where he has been working ever since. He was promoted to Assistant Professor in 2019. His research interest is the discovery of bioactive products from traditional Chinese medicines and other natural sources with potential application as medicines. He has authored 30+ papers, 4 patents, and 2 monographs. He is reviewer and guest editor as well as editorial board member for multiple journals. 


Image

Zhongrui Li, MD, PhD

Zhongrui Li received her PhD in Medicinal Chemistry in 2019 from Zhengzhou University and continued her 2-year postdoctoral research at Nanjing Medical University. Her research interests include the discovery, structure, and bioactivity of natural products. She has authored 20 scientific publications. 

 

Natural products (NPs) have present abundant scaffold diversity and structural complexity, and have contributed greatly in drug discovery efforts especially for anticancer drugs. As an example, Professor Youyou Tu was awarded the 2015 Nobel Prize for discovering artemisinin from Artemisia annua. While natural active ingredients are important sources of novel anticancer drugs, NPs often exhibit unfavorable physicochemical and pharmacokinetics properties, such as low solubility, poor bioavailability, and systemic toxicity, which limit their potential for clinical application. Thus, nanodrug delivery systems, such as liposomes, polymer colloids, carbon nanomaterials, metal-organic framework, and magnetic nanocarriers, have been developed to overcome the unsuitable properties of NPs and improve their therapeutic efficacy for cancer.

For this special issue, we invite front-line researchers and scientists to submit high-quality scientific manuscripts related to the development of nanodrug delivery systems for cancer treatment. Potential topics include, but are not limited to:

  • New nanomaterials and nanotechnologies used in nanoparticles for NP delivery 
  • NP nanodelivery systems with systemic antitumor properties 
  • Targeted delivery and controlled release of NP-based nanomedicine 
  • Intelligent theranostic NP-based nanomedicine 
  • Carrier-free NP nanoplatforms 
  • Antitumor mechanism of nanoparticles for NP delivery 
  • Clinical studies of nanoparticles for NP delivery 

 

Authors should refer to the Instructions for Authors  in preparing  the manuscript and kindly submit it through the Online Submission System directly.

 

Priority will be given with the same high standards of peer review and publication process for these articles. Authors publishing papers regarding nanodrug delivery systems for cancer treatment will not be charged any fees, and all publications will be available with free open access to all readers. Additionally, all accepted papers related to nanodrug delivery systems for cancer treatment will be highlighted in a special section on our website.

 

Online submission system: https://www.publinexh.com/ 

Article processing charge: None

Instructions for authors: Please state in a cover letter that the manuscript is being submitted for inclusion in the special issue ‘Natural active ingredient–based nanodrug delivery system for cancer treatment’, and follow the usual JERP instructions. Please refer to: https://www.xiahepublishing.com/journal/jerp/instruction

For any inquiries, please contact the journal by e-mail: [email protected]